HENRY A MCKINNELL
CIK 1174453 · CEO and Chairman of the Board · last filed 2022-05-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$109.23M
Companies
8
Total Filings
116
Lifetime Open-Market Net
$1.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CCXI | Director | 72,749 | $14.52 | $1.06M | $0 | 8 | 2022-05-24 |
| MCO | Director | 89,487 | $484.20 | $43.33M | $0 | 78 | 2021-03-19 |
| Federal Street Acquisition Corp. (FSACW) Delisted | Director | 25,000 | — | — | $0 | 1 | 2019-01-04 |
| ViewRay, Inc. (VRAY) Delisted | Director | 689,046 | $0.03 | $17.2K | $1.98M | 8 | 2019-01-03 |
| ANGIOTECH PHARMACEUTICALS INC (ANPI) Delisted | Director | — | — | — | $0 | 2 | 2009-12-14 |
| ANGIOTECH PHARMACEUTICALS INC (JRT) Delisted | Director | — | — | — | $0 | 2 | 2008-12-15 |
| XOM | Director | 36,400 | $153.04 | $5.57M | $0 | 2 | 2007-04-03 |
| PFE | Director | 2,347,539 | $25.25 | $59.28M | $0 | 5 | 2007-03-02 |
Recent Filings · Page 3 of 12
116 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-11 | MCO | Grant (A) | +127 | $22.5K | EDGAR |
| 2018-07-05 | ViewRay, Inc. (VRAY) Delisted | Grant (A) | +3,160 | $22.5K | EDGAR |
| 2018-06-13 | MCO | Grant (A) | +125 | $22.3K | EDGAR |
| 2018-05-23 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2018-04-25 | ViewRay, Inc. (VRAY) Delisted | Grant (A) | +4,987 | $0 | EDGAR |
| 2018-03-13 | MCO | Grant (A) | +129 | $22.0K | EDGAR |
| 2018-02-20 | MCO | Grant (A) | +1,493 | $0 | EDGAR |
| 2017-12-13 | MCO | Grant (A) | +124 | $19.0K | EDGAR |
| 2017-09-13 | MCO | Grant (A) | +140 | $19.0K | EDGAR |
| 2017-06-13 | MCO | Grant (A) | +162 | $18.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.